Oncologic outcomes of breast-conserving surgery following neoadjuvant versus adjuvant chemotherapy: a brazilian multicenter cohort study
Introduction: Neoadjuvant chemotherapy (NAC) is a cornerstone in breast cancer treatment, particularly for locally advanced, triple-negative, and human epidermal growth factor receptor 2 (HER2)-positive disease. However, concerns remain regarding the oncologic safety of breast-conserving surgery (BCS) following NAC com...